[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356643-105":59,"doc-detail-356643-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","network-pharmacology-and-molecular-docking-analysis-on-mechanisms-of-euphorbia-lathyris-l-seed-in-treating-colorectal-cancer-research-open-access","Network pharmacology and molecular docking analysis on mechanisms of Euphorbia Lathyris L. seed in treating colorectal cancer - research open access","","Euphorbia Lathyris L. Seed (ELLS), a traditional Chinese medicine used in China, is investigated for its synergistic mechanism against colorectal cancer (CRC) using network pharmacology and molecular docking. Related compounds are collected and screened with ADME, and drug-target relationships are built from multiple databases. CRC-related targets are integrated from GeneCards, TTD, and OMIM; C-T networks and C-T-P pathway visualizations are generated in Cytoscape, followed by STRING PPI analysis, GO/KEGG enrichment, survival analysis, and AutoDock Vina docking. In vitro validation uses HCT116 and SW620 cells.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/network-pharmacology-and-molecular-docking-analysis-on-mechanisms-of-euphorbia-lathyris-l-seed-in-treating-colorectal-cancer-research-open-access/356643/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/network-pharmacology-and-molecular-docking-analysis-on-mechanisms-of-euphorbia-lathyris-l-seed-in-treating-colorectal-cancer-research-open-access/356643.png","ImageObject",300,407,{"name":92,"@type":93},"Alex Sinclair","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of this study on Euphorbia Lathyris L. seed?","Question",{"text":112,"@type":113},"To reveal the synergistic mechanism of ELLS in treating colorectal cancer using network pharmacology and molecular docking, with in vitro experiments planned to verify efficacy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were active compounds and drug-target relationships identified?",{"text":117,"@type":113},"ELLS-related compounds were retrieved from TCMSP, then active compounds were screened by ADME. Drug-target links were captured using TCMSP, BATMAN-TCM, STITCH, Swiss Target Prediction, and literature resources.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key outcomes of the network pharmacology analysis?",{"text":121,"@type":113},"Twelve active compounds and 173 associated targets were identified. Key targets in the C-T-P network included AKT1, CASP3, ESR1, TNF, and HSP90AA1, and pathway enrichment indicated multiple cancer-related pathways affected by ELLS.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356643,1790649335,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Gao et al. BMC Cancer (2026) 26:501 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15778-w](https://doi.org/10.1186/s12885-026-15778-w)  \nRESEARCH Open Access  \nNetwork pharmacology and molecular  docking analysis on mechanisms of Euphorbia Lathyris L. seed in treating colorectal cancer  \nXiaohong Gao1, Hongjuan Zhang1, Yilin Wang1 and Peizhen Hu 1*  \nAbstract  \nBackground Euphorbia Lathyris L. Seed (ELLS) is aTraditional Chinese Medicine (TCM), which has long been used in China. This study was designed to reveal the synergistic mechanism of ELLS in the treatment of colorectal cancer (CRC) by using network pharmacology method and molecular docking. In addition, related in vitro experiments will be conducted to verify the efficacy of ELLS.  \nMethods ELLS related compounds were obtained from TCMSP database. Then active compounds were screened by ADME (absorption, distribution, metabolism, and excretion) . Additionally, TCMSP, BATMAN-TCM, STITCH, Swiss Target Prediction and literatures were used to capture the relationships between drugs and targets. A compound-target (C-T) network was established by Cytoscape. Target genes related to CRC were acquired from GeneCards, TTD and OMIM databases. Correlations about compound-target-pathway (C-T-P) were visualized by Cytoscape. The proteinprotein interaction (PPI) network was constructed by STRING. Gene survival analysis came from the GEPIA2 . Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed via metascape. Molecular docking analysis was constructed by the AutoDock Vina. And the efficacy of ELLSin combating CRC was verified using HCT116 and SW620 cells.  \nResults A total of 12 active compounds and 173 associated targets of ELLS compounds were identified. Sixtythree common genes were obtained by matching 173 potential genes of ELLS with 1554 CRC related genes and PPI network screened out key targets, including AKT1, CASP3, ESR1, TNF, HSP90AA1 . Five core compounds were beta-sitosterol, stigmasterol, euphol, Artemetin and lathyrol. Eight core targets were PRKACA, PRKCA, AR, BAX, GSK3B, NFKB1, RXRA and NCOA2 in the C-T-P network. KEGG pathway analysis indicated that ELLS effectively treated CRC through regulation of pathways in cancer, Epstein-Barr virus infection, thyroid hormone signaling pathway,  \nbile secretion, and transcriptional misregulation in cancer. Gene survival analysis showed that 7 genes (APAF1, APOE, CASP3, HDAC2, NFKB1, PGR, and SNAI1) were significantly related in CRC patients’ survival and prognosis. Molecular docking results suggested that almost all of the core compound-targets had an excellent binding activity (affinity \u003C − 5 kcal/mol) . CCK8 results indicated that ELLS (20 µg/mL, 24-hour treatment) significantly inhibited the proliferation of HCT116 cells, while it had minimal impact on the viability of normal NCM460 cells under the same conditions (survival rate ≥ 80%) .  \n*Correspondence: Peizhen Hu[hupz54633@163.com](hupz54633@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need","cbCairfQ6kfJQ2sB","https://ap.wps.com/l/cbCairfQ6kfJQ2sB","pdf",4787312,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the purpose of this study on Euphorbia Lathyris L. seed?\",\"answer\":\"To reveal the synergistic mechanism of ELLS in treating colorectal cancer using network pharmacology and molecular docking, with in vitro experiments planned to verify efficacy.\"},{\"question\":\"How were active compounds and drug-target relationships identified?\",\"answer\":\"ELLS-related compounds were retrieved from TCMSP, then active compounds were screened by ADME. Drug-target links were captured using TCMSP, BATMAN-TCM, STITCH, Swiss Target Prediction, and literature resources.\"},{\"question\":\"What were the key outcomes of the network pharmacology analysis?\",\"answer\":\"Twelve active compounds and 173 associated targets were identified. Key targets in the C-T-P network included AKT1, CASP3, ESR1, TNF, and HSP90AA1, and pathway enrichment indicated multiple cancer-related pathways affected by ELLS.\"}]","Network pharmacology and molecular docking analysis on mechanisms of Euphorbia Lathyris L. seed in treating colorectal cancer - research open access | PDF",1790126555,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/165b5437b0b26f3d08322ebfaeb943b4.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74bd588f63a2064683c6d5dfe2f312cc.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ff25677aadc4fb071192035da0db2cd.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61ad1275825b080c6e3bf01b51855002.webp",980,1306]